Jose Carmona
CIK 1693612 · Chief Financial Officer · last filed 2026-02-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$798.3K
Companies
3
Total Filings
12
Lifetime Open-Market Net
$75.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADCT | Chief Financial Officer | 760,256 | $1.05 | $798.3K | $0 | 4 | 2026-02-18 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Chief Financial Officer | — | $0.08 | — | $0 | 2 | 2022-02-01 |
| Radius Health, Inc. (RDUS) Delisted | Chief Financial Officer | 46,708 | $30.00 | $1.40M | $75.3K | 6 | 2020-02-28 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-15 | Radius Health, Inc. (RDUS) Delisted | Buy (P) | +3,000 | $98.5K | EDGAR |
| 2017-05-16 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.